Discussion on the Practice of Innovation Subsidy Mechanism of Biomedical Industry at Home and Abroad——Based on the Analysis of Guangzhou Bio-Pharmaceutical Post-Subsidy Project
Biomedical industry is closely related to life and health,and has always occupied an important position in the economic development of all countries in the world.Article summarizes the current domestic and foreign scholars of biomedical industry policy research,in Guangzhou in 2020 after the biological medicine industry subsidy policy as an opportunity,summarizes the analysis of 2020-2022 Guangzhou biological medicine industry policy subsidies and existing problems,draw lessons from the experience of countries and regions,put forward"improve the Guangzhou biological medicine industry as a whole management,promote biological medicine industry scientific and technological achievements,encourage pharmaceutical companies and medical institutions to carry out clinical trials,strengthen the biological medicine industry subsidy policy propaganda,multi-channel development of biological medicine industry"policy advice.
Biological medicinepost-subsidypharmaceutical industryscience and technology management